Kailera Therapeutics, Inc. Common Stock (KLRA) is a publicly traded the market company. As of May 21, 2026, KLRA trades at $20.10 with a market cap of $2.53B and a P/E ratio of 0.00. KLRA moved +2.34% today. Year to date, KLRA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $19.01 to $28.23. Analyst consensus is strong buy with an average price target of $45.00. Rallies surfaces KLRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Kailera Therapeutics, Inc. Common Stock (KLRA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KLRA moved +2.34% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $20.10 |
| Market Cap | $2.53B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.23 |
| 52-Week Low | $19.01 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover KLRA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.00.